s6y
Company name or ticker
Search
Artiva Biotherapeutics, Inc.
4
Aslan Fred: Statement of changes in beneficial ownership of securities
Filed
Wednesday, October 7, 2026
Period
Oct 6, 2026
Accession number
0001193125-26-416953
Documents
4
4
On sec.gov
Filing index
All files
Complete submission text
SGML header